Spyre Therapeutics, Inc.
USD87.89
-0.78 (-0.88%)
CEO
Cameron Turtle
IPO Date
2016-04-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$88.44
Prev. Close
$88.67
Day Low
$85.97
Day High
$89.88
52W Low
$14.00
52W High
$102.06
Market Cap
$5.31B
Volume
4.44M
| 5,000 |
| $87.12 |
| 26 Jun 2026 | Burrows Scott L | Chief Financial Officer | S-Sale | Disposed | 10,000 | $87.14 |
| 26 Jun 2026 | Burrows Scott L | Chief Financial Officer | M-Exempt | Disposed | 15,000 | $14.50 |
| 23 Jun 2026 | Fairmount Funds Management LLC | director | C-Conversion | Acquired | 666,680 | $0.00 |
| 23 Jun 2026 | Fairmount Funds Management LLC | director | S-Sale | Disposed | 4,684,781 | $85.31 |
| 23 Jun 2026 | Fairmount Funds Management LLC | director | C-Conversion | Disposed | 16,667 | $0.00 |
| 23 Jun 2026 | HENDERSON MICHAEL THOMAS | director | S-Sale | Disposed | 20,000 | $100.00 |
| 3 Jun 2026 | Sloan Sheldon | Chief Medical Officer | M-Exempt | Acquired | 8,333 | $27.46 |
| 3 Jun 2026 | Sloan Sheldon | Chief Medical Officer | S-Sale | Disposed | 8,333 | $75.00 |